Cargando…
Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
BACKGROUND: The circulating soluble TNF-like weak inducer of apoptosis (sTWEAK) is a cytokine that modulates inflammatory and atherogenic reactions related to cardiometabolic risk. We investigated the association between sTWEAK levels and metabolic syndrome (MetS) and its components in older subject...
Autores principales: | Díaz-López, Andrés, Bulló, Mònica, Chacón, Matilde R, Estruch, Ramón, Vendrell, Joan, Díez-Espino, Javier, Fitó, Montserrat, Corella, Dolores, Salas-Salvadó, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974038/ https://www.ncbi.nlm.nih.gov/pubmed/24565471 http://dx.doi.org/10.1186/1475-2840-13-51 |
Ejemplares similares
-
HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015) -
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022) -
The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020) -
The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
por: Comertpay, Ertan, et al.
Publicado: (2020) -
sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage
por: da Silva-Candal, Andrés, et al.
Publicado: (2021)